Cahir MedTech

From development to commercialization

MedTech Lifecycle Glossary

103 terms across device development, clinical evidence, manufacturing, supply chains, market access and postmarket monitoring — with plain-English definitions and primary sources.

Device category

103 of 103 terms shown

Device categories indicate topic relevance, not legal applicability. Cross-device terms remain included.

21 CFR Part 11
AI and software

21 CFR Part 11 sets FDA requirements for electronic records and electronic signatures to be trustworthy, reliable and equivalent to paper.

Cross-device relevance

Why it matters for founders: eQMS, ELN and clinical data systems that hold required records need validation, audit trails and access controls.

Related: QMS, SaMD

510(k)Premarket Notification
Premarket

A 510(k) is an FDA premarket submission showing that a new device is substantially equivalent to a legally marketed predicate device.

Cross-device relevance

Why it matters for founders: It is the most common US route to market for moderate-risk (Class II) devices, and your predicate choice shapes your testing plan.

Related: Substantial Equivalence, Predicate Device, eSTAR, Q-Sub (Pre-Sub)

FDA Q-Sub Master Pack

$499 USD · One-time · Applicable taxes may apply

Buy the Kit
Analytical Performance
Development and clinical

Analytical performance describes how well a diagnostic test measures or detects its target analyte, including characteristics such as precision, detection limits, interference and analytical specificity, as applicable.

IVD and diagnostics

Why it matters for founders: Strong analytical results are necessary but do not alone prove clinical usefulness.

Related: In Vitro Diagnostic (IVD), Clinical Performance, Verification and Validation (V&V)

Breakthrough Device Designation
Premarket

Breakthrough Device Designation is an FDA program that offers more interactive review for devices that may provide more effective treatment or diagnosis of life-threatening or irreversibly debilitating conditions.

Cross-device relevance

Why it matters for founders: Designation gives more frequent FDA interaction and prioritized review, but it does not lower the evidence standard for authorization.

Related: Q-Sub (Pre-Sub), De Novo, PMA

CAPACorrective and Preventive Action
Quality system

CAPA is the quality-system process for investigating the cause of nonconformities and complaints, correcting them and preventing them from recurring.

Cross-device relevance

Why it matters for founders: CAPA records are among the first things FDA investigators review, and weak CAPA is a frequent Form 483 observation.

Related: Form 483, QMSR, ISO 13485

QMSR Form 483 Response Kit

$299 USD · One-time · Applicable taxes may apply

Buy the Kit
CDRHCenter for Devices and Radiological Health
Premarket

CDRH is the FDA center responsible for regulating medical devices and radiation-emitting products in the United States.

Cross-device relevance

Why it matters for founders: CDRH review divisions handle your Q-Subs and premarket submissions, and its guidance documents define current expectations.

Related: Q-Sub (Pre-Sub), 510(k), PMA

CE Marking
Market access

CE marking shows that a device conforms to the EU MDR (or IVDR) and may be placed on the European Economic Area market.

Cross-device relevance

Why it matters for founders: It is not an FDA equivalent; US clearance and CE marking require separate evidence packages and reviews.

Related: EU MDR, Notified Body, UKCA

Change Control
Quality system

Change control is the documented review, approval and implementation of changes to products or quality-system processes, including assessment of risks, required testing and any regulatory submission impact.

Cross-device relevance

Why it matters for founders: A quality approval alone does not determine whether FDA needs a new submission.

Related: Design Controls, PCCP, Process Validation

PCCP-to-QMSR Mapping Kit

$199 USD · One-time · Applicable taxes may apply

Buy the Kit
Clinical Evaluation Report (CER)
Market access

Under the EU MDR, a clinical evaluation report documents the analysis of clinical data that demonstrates a device's safety, performance and clinical benefit.

Cross-device relevance

Why it matters for founders: Notified Bodies scrutinize the CER closely, and it must be updated with postmarket clinical follow-up data.

Related: EU MDR, Notified Body, Postmarket Surveillance

Clinical Evidence
Development and clinical

Clinical evidence is clinical data and its evaluation used to support a device's safety, performance or effectiveness for its intended use. What is sufficient depends on the device, claims and regulatory pathway.

Cross-device relevance

Why it matters for founders: The same evidence package may not satisfy regulators, clinicians and payers.

Related: IDE, Real-World Evidence (RWE), Clinical Evaluation Report (CER)

Hospital VAC Dossier Pack

$299 USD · One-time · Applicable taxes may apply

Buy the Kit
Clinical Performance
Development and clinical

For an IVD, clinical performance describes how test results relate to the clinical condition or physiological state in the intended population, using measures appropriate to the claim such as clinical sensitivity and specificity.

IVD and diagnostics

Why it matters for founders: Your study population and reference method must support the diagnostic claim.

Related: In Vitro Diagnostic (IVD), Analytical Performance, Clinical Evidence

Complaint Handling
Risk and postmarket

Complaint handling is the documented process for receiving, reviewing and investigating reports that allege deficiencies in a device's identity, quality, durability, reliability, safety, effectiveness or performance.

Cross-device relevance

Why it matters for founders: Each complaint must be assessed for reportability, so weak complaint files lead to missed MDRs and inspection findings.

Related: MDR (Medical Device Reporting), CAPA, Postmarket Surveillance

21 CFR to ISO 13485 Mapping Kit

$199 USD · One-time · Applicable taxes may apply

Buy the Kit
Contract Manufacturing
Manufacturing and supply chain

Contract manufacturing is production performed by an external organization for a device company. Outsourcing does not remove the device company's responsibility to control outsourced processes and meet applicable requirements.

Cross-device relevance

Why it matters for founders: Define quality responsibilities, change notifications and acceptance criteria before transferring production.

Related: Supplier Controls, Design Transfer, Medical Device Manufacturing

Cost-to-charge ratio (CCR)Hospital cost-to-charge ratio
Market access

A CCR describes the relationship between hospital costs and billed charges. CMS uses applicable hospital ratios in particular payment calculations; a national planning ratio is not every hospital's charge policy.

Cross-device relevance

Why it matters for founders: Device acquisition cost, billed charges and Medicare payment are different. A charge conversion does not determine collections, NTAP payment or profit.

Related: NTAP cost threshold, NTAP standardized case charges, Inpatient outlier payment

CPT and HCPCS codes
Market access

CPT and HCPCS are the US procedure and supply code sets that providers use to bill payers for services and devices.

Cross-device relevance

Why it matters for founders: FDA authorization does not guarantee payment; without a usable code, coverage and payment, hospitals may hesitate to buy.

Related: Value Analysis Committee (VAC)

Reimbursement & Coding Roadmap

$299 USD · One-time · Applicable taxes may apply

Buy the Kit
Cyber Device (Section 524B)
AI and software

Under section 524B of the FD&C Act, a cyber device includes software, can connect to the internet and could be vulnerable to cybersecurity threats; its submissions must include cybersecurity information.

SaMD and AI · IVD and diagnostics · Electrical and connected devices

Why it matters for founders: Submissions must include a vulnerability monitoring plan, secure-design evidence and an SBOM, or FDA can refuse to accept them.

Related: SBOM, SaMD

De NovoDe Novo classification request
Premarket

De Novo is an FDA pathway that classifies a novel low-to-moderate-risk device with no valid predicate into Class I or Class II.

Cross-device relevance

Why it matters for founders: A granted De Novo creates a new device type that later products, including competitors, can use as a 510(k) predicate.

Related: 510(k), Q-Sub (Pre-Sub), Predicate Device

FDA Q-Sub Master Pack

$499 USD · One-time · Applicable taxes may apply

Buy the Kit
Design Controls
Quality system

Design controls are the planned, documented checks — inputs, outputs, reviews, verification, validation, transfer and changes — that show a device was designed to meet user needs.

Cross-device relevance

Why it matters for founders: Design-control evidence feeds your submission and your DHF; reconstructing it after the fact is slow and costly.

Related: DHF, ISO 13485, QMSR

21 CFR to ISO 13485 Mapping Kit

$199 USD · One-time · Applicable taxes may apply

Buy the Kit
Design Inputs
Development and clinical

Design inputs are documented requirements for a device's function, performance, usability, safety and applicable regulatory requirements, informed by its intended use and user needs.

Cross-device relevance

Why it matters for founders: Clear, testable inputs make verification and design decisions traceable.

Related: Intended Use and Indications for Use, Design Outputs, Verification and Validation (V&V)

Design Outputs
Development and clinical

Design outputs are the documented results of design and development, such as specifications, drawings and software, that meet inputs and provide information for purchasing, production and service.

Cross-device relevance

Why it matters for founders: Outputs become the controlled instructions needed to make and test your product consistently.

Related: Design Inputs, Design Transfer, DMR

Design Transfer
Manufacturing and supply chain

Design transfer is the controlled translation of design outputs into suitable production specifications, with confirmation that production can meet product requirements.

Cross-device relevance

Why it matters for founders: A working prototype alone does not establish readiness for repeatable commercial production.

Related: Design Outputs, Medical Device Manufacturing, Process Validation

Device Classification (Class I, II, III)
Premarket

FDA places each device type into Class I, II or III based on its risk and the controls needed to provide reasonable assurance of safety and effectiveness.

Cross-device relevance

Why it matters for founders: Your class largely decides your pathway: most Class I devices are 510(k)-exempt, most Class II need a 510(k), and Class III usually needs a PMA.

Related: 510(k), De Novo, PMA, Product Code

DHFDesign History File
Quality system

A Design History File (DHF) is the compiled record showing how a device was designed and developed under design controls.

Cross-device relevance

Why it matters for founders: Under QMSR the term maps to the ISO 13485 design and development file, but investigators still expect complete, traceable design records.

Related: Design Controls, DMR, DHR, QMSR

21 CFR to ISO 13485 Mapping Kit

$199 USD · One-time · Applicable taxes may apply

Buy the Kit
DHRDevice History Record
Quality system

A Device History Record (DHR) is the production record showing that each batch, lot or unit was manufactured according to its approved specifications.

Cross-device relevance

Why it matters for founders: Under QMSR these become ISO 13485 batch/production records, which must still trace each unit to its acceptance results.

Related: DMR, DHF, UDI

21 CFR to ISO 13485 Mapping Kit

$199 USD · One-time · Applicable taxes may apply

Buy the Kit
DMRDevice Master Record
Quality system

A Device Master Record (DMR) is the full set of specifications, procedures and drawings needed to build, test, label and service a device.

Cross-device relevance

Why it matters for founders: Under QMSR it aligns with the ISO 13485 medical device file, so manufacturers often restructure their DMR during transition.

Related: DHF, DHR, QMSR

21 CFR to ISO 13485 Mapping Kit

$199 USD · One-time · Applicable taxes may apply

Buy the Kit
Establishment Registration and Device Listing
Market access

FDA establishment registration identifies facilities involved in specified device activities; device listing identifies their devices and activities. Registration or listing does not mean that FDA has cleared, approved or endorsed a device or facility.

Cross-device relevance

Why it matters for founders: Determine obligations for your activity and maintain them separately from product authorization.

Related: Medical Device Commercialization, 510(k), PMA

eSTARelectronic Submission Template And Resource
Premarket

eSTAR is FDA's interactive PDF template for preparing medical device submissions such as 510(k)s and De Novo requests.

Cross-device relevance

Why it matters for founders: FDA requires eSTAR for most 510(k)s, and the template's built-in checks reduce the risk of an incomplete-submission hold.

Related: 510(k), De Novo

EU AI ActRegulation (EU) 2024/1689
AI and software

The EU's risk-based law on artificial intelligence; AI systems that are safety components of, or are, medical devices needing notified-body review are generally classed as high-risk.

Cross-device relevance

Why it matters for founders: High-risk obligations (risk management, data governance, human oversight, logging) add to EU MDR/IVDR requirements, with staged application dates.

Related: EU GDPR, NIST AI RMF

EU GDPRGeneral Data Protection Regulation (EU) 2016/679
Risk and postmarket

The EU's data protection law; health data is a special category that needs a specific legal basis and extra safeguards.

Cross-device relevance

Why it matters for founders: AI tools processing EU patient data need lawful processing, data-protection impact assessments and controls on transfers outside the EU.

Related: HIPAA, EU AI Act

EU MDREU Medical Device Regulation 2017/745
Market access

The EU MDR is Regulation (EU) 2017/745, the law that sets requirements for placing medical devices on the European Union market.

Cross-device relevance

Why it matters for founders: Most devices need a Notified Body certificate and stronger clinical evidence than under the old directives before CE marking.

Related: UKCA, ISO 13485, MDSAP

FDA AI-enabled device guidance
AI and software

FDA's resources and guidance for AI-enabled medical devices, including its public list of authorized AI-enabled devices and recommendations on lifecycle management and PCCPs.

Cross-device relevance

Why it matters for founders: Buyers can confirm a product's FDA authorization and intended use, and check whether a PCCP covers future model updates.

Related: PCCP, GMLP, Procurement Readiness Score

FedRAMPFederal Risk and Authorization Management Program
Risk and postmarket

The US government program that standardizes security assessment and authorization of cloud services used by federal agencies.

Cross-device relevance

Why it matters for founders: Required for cloud AI tools sold to federal health systems such as the VA; also a strong security signal elsewhere.

Related: SOC 2, NIST CSF

Form 483FDA Form 483, Inspectional Observations
Quality system

A Form 483 lists the conditions an FDA investigator observed during an inspection that may violate FDA requirements.

Cross-device relevance

Why it matters for founders: A thorough response within 15 business days can help prevent escalation to a Warning Letter.

Related: Warning Letter, CAPA, QMSR

QMSR Form 483 Response Kit

$299 USD · One-time · Applicable taxes may apply

Buy the Kit
GMLPGood Machine Learning Practice
AI and software

Good Machine Learning Practice (GMLP) describes practices for safe, effective, high-quality AI/ML medical device development across the product life cycle. IMDRF published 10 guiding principles in January 2025, building on the FDA, Health Canada and MHRA principles from 2021; these principles are not a standalone certification or binding regulation.

SaMD and AI · IVD and diagnostics · Electrical and connected devices

Why it matters for founders: Reviewers look for GMLP themes — representative data, independent test sets, human-AI performance — in AI device submissions.

Related: PCCP, SaMD

AI/ML PCCP Suite

$399 USD · One-time · Applicable taxes may apply

Buy the Kit
Good Clinical Practice (GCP)
Development and clinical

Good clinical practice describes ethical and scientific quality practices for clinical investigations, including protecting participants and producing credible data. ISO 14155 addresses clinical investigations of medical devices for human subjects.

Cross-device relevance

Why it matters for founders: Build consent, oversight and data-quality safeguards into a study before enrollment.

Related: IDE, Clinical Evidence

Health Economics and Outcomes Research (HEOR)
Market access

HEOR evaluates health outcomes, resource use, costs and the value of interventions. Studies may include economic evaluations and real-world outcomes analysis; it is an evidence discipline, not a regulatory clearance pathway.

Cross-device relevance

Why it matters for founders: It helps demonstrate value to payers and hospital purchasers beyond technical performance.

Related: Real-World Evidence (RWE), Reimbursement, Value Analysis Committee (VAC)

Hospital VAC Dossier Pack

$299 USD · One-time · Applicable taxes may apply

Buy the Kit
HIPAAHealth Insurance Portability and Accountability Act
Risk and postmarket

US federal law whose Privacy, Security and Breach Notification Rules govern how covered entities and their business associates protect health information.

Cross-device relevance

Why it matters for founders: AI vendors that handle patient data usually sign a business associate agreement and must meet HIPAA Security Rule safeguards.

Related: EU GDPR, SOC 2

Human Factors / Usability Engineering
Risk and postmarket

Human factors (usability) engineering studies how intended users interact with a device to reduce use errors that could cause harm; IEC 62366-1 is the recognized standard.

Cross-device relevance

Why it matters for founders: FDA expects human factors validation data for devices with critical tasks, and use-related risks feed your ISO 14971 risk file.

Related: ISO 14971, Verification and Validation (V&V)

IDEInvestigational Device Exemption
Premarket

An Investigational Device Exemption (IDE) allows an investigational device to be used in a clinical study to collect safety and effectiveness data.

Cross-device relevance

Why it matters for founders: Significant-risk device studies need FDA IDE approval before enrollment; a Pre-Sub can help align on the study design first.

Related: Q-Sub (Pre-Sub), PMA

FDA Q-Sub Master Pack

$499 USD · One-time · Applicable taxes may apply

Buy the Kit
IEC 60601-1Medical electrical equipment — basic safety and essential performance
Premarket

IEC 60601-1 is the core international standard for the basic safety and essential performance of medical electrical equipment, supported by collateral and particular standards.

Electrical and connected devices · Implantable devices

Why it matters for founders: Powered devices usually need accredited-lab 60601 testing, which often sets the critical path for submission.

Related: Verification and Validation (V&V), ISO 14971

IEC 62304Medical device software — Software life cycle processes
AI and software

IEC 62304 is the international standard that defines life-cycle processes for developing and maintaining medical device software, scaled by software safety class.

SaMD and AI · IVD and diagnostics · Electrical and connected devices

Why it matters for founders: FDA recognizes it and EU Notified Bodies expect it, so aligning early avoids rework of software documentation.

Related: SaMD, SBOM, ISO 14971

In Vitro Diagnostic (IVD)
Premarket

An in vitro diagnostic is a reagent, instrument or system used to examine specimens taken from the human body to provide information about health, disease or other conditions.

IVD and diagnostics

Why it matters for founders: Diagnostic claims determine the performance studies, labeling and review pathway you need.

Related: Analytical Performance, Clinical Performance, Device Classification (Class I, II, III)

Inpatient outlier payment
Market access

Outlier payment is a separate Medicare inpatient mechanism for extraordinarily costly cases that meet the applicable fixed-loss threshold and payment conditions.

Cross-device relevance

Why it matters for founders: It is not routine reimbursement for an expensive implant and is distinct from NTAP eligibility and add-on payment. Use the applicable year's rules.

Related: NTAP, IPPS, Cost-to-charge ratio (CCR)

Intended Use and Indications for Use
Premarket

Intended use is the general purpose of a device; indications for use describe the disease or condition it diagnoses, treats, prevents or mitigates, and the target population.

Cross-device relevance

Why it matters for founders: These statements drive classification, predicate comparison, clinical evidence and what marketing claims you may make.

Related: 510(k), Substantial Equivalence, Labeling

FDA Q-Sub Master Pack

$499 USD · One-time · Applicable taxes may apply

Buy the Kit
IPPSInpatient Prospective Payment System
Market access

IPPS is Medicare's case-based payment system for many acute inpatient hospital stays, using MS-DRGs with hospital and case adjustments rather than paying separately for each device.

Cross-device relevance

Why it matters for founders: Confirm the care setting first: inpatient NTAP is not an outpatient payment mechanism or a direct payment to a device maker.

Related: NTAP, MS-DRG

IQ / OQ / PQInstallation, Operational and Performance Qualification
Manufacturing and supply chain

IQ checks correct installation; OQ challenges operation across defined conditions; PQ demonstrates consistent performance under anticipated routine conditions. These are common qualification stages within a process-validation approach.

Cross-device relevance

Why it matters for founders: Qualification connects equipment setup and operating limits to repeatable production evidence.

Related: Process Validation, Medical Device Manufacturing

ISO 10993 (Biocompatibility)
Premarket

ISO 10993-1 sets the framework for evaluating the biological safety of device materials that contact the body, within a risk management process.

Implantable devices · General medical devices · IVD and diagnostics · Electrical and connected devices

Why it matters for founders: FDA's biocompatibility guidance builds on ISO 10993-1; contact type and duration decide which tests you need.

Related: ISO 14971, Verification and Validation (V&V)

ISO 13485ISO 13485:2016 Medical devices — Quality management systems
Quality system

ISO 13485:2016 is the international standard that specifies quality management system requirements for organizations involved in the medical device life cycle.

Cross-device relevance

Why it matters for founders: FDA's QMSR incorporates ISO 13485 by reference, so one QMS can serve US, EU, Canada and other markets.

Related: QMSR, QMS, MDSAP, ISO 14971

21 CFR to ISO 13485 Mapping Kit

$199 USD · One-time · Applicable taxes may apply

Buy the Kit
ISO 14971ISO 14971:2019 Application of risk management to medical devices
Risk and postmarket

ISO 14971:2019 is the international standard for identifying, evaluating, controlling and monitoring risks of medical devices throughout their life cycle.

Cross-device relevance

Why it matters for founders: FDA recognizes ISO 14971, and your risk file connects design inputs, verification, labeling and postmarket monitoring.

Related: ISO 13485, Design Controls, Postmarket Surveillance

Labeling
Risk and postmarket

Under FDA law, labeling includes the device label and all written, printed or graphic material accompanying the device, such as instructions for use.

Cross-device relevance

Why it matters for founders: Claims in labeling and promotion must stay within your cleared or approved indications.

Related: Intended Use and Indications for Use, UDI

MDR (Medical Device Reporting)
Risk and postmarket

Medical Device Reporting (21 CFR Part 803) requires manufacturers to report deaths, serious injuries and certain malfunctions involving their devices to FDA.

Cross-device relevance

Why it matters for founders: Most reportable events must be submitted within 30 calendar days, so complaint handling must flag them quickly. Not to be confused with the EU MDR.

Related: Postmarket Surveillance, CAPA, EU MDR

MDSAPMedical Device Single Audit Program
Quality system

MDSAP lets one recognized auditing organization audit a manufacturer's QMS against the requirements of the US, Canada, Brazil, Japan and Australia.

Cross-device relevance

Why it matters for founders: MDSAP is mandatory for Health Canada and can replace routine FDA inspections, reducing audit burden for multi-market companies.

Related: ISO 13485, QMSR

CP 7382.850 Mock Inspection Kit

$299 USD · One-time · Applicable taxes may apply

Buy the Kit
Medical Device Commercialization
Market access

Commercialization is the practical transition from a developed device to lawful marketing, distribution and adoption. It combines applicable authorization and quality obligations with production capacity, sales, market access and ongoing support.

Cross-device relevance

Why it matters for founders: Clearance is one milestone; sustainable adoption also requires delivery capacity and customer evidence.

Related: Medical Device Manufacturing, Reimbursement, Value Analysis Committee (VAC), Establishment Registration and Device Listing

Hospital VAC Dossier Pack

$299 USD · One-time · Applicable taxes may apply

Buy the Kit
Medical Device Manufacturing
Manufacturing and supply chain

Medical device manufacturing encompasses controlled activities that turn materials and components into finished devices, including production, inspection, packaging and release under the applicable quality system.

Cross-device relevance

Why it matters for founders: Scaling output must preserve specifications, traceability and validated processes.

Related: Design Transfer, Process Validation, DHR, Supplier Controls

Medical Device Supply Chain
Manufacturing and supply chain

The medical device supply chain is the network of organizations and activities that source materials, manufacture devices and deliver them to users. Quality issues, interruptions and shortages can affect availability and patient care.

Cross-device relevance

Why it matters for founders: Map critical dependencies and alternative supply options alongside supplier quality oversight.

Related: Supplier Controls, Contract Manufacturing, Supply Chain Resilience, Section 506J Shortage Notification

Model Drift
AI and software

Model drift describes changes over time in data or relationships that can reduce an AI model's performance in use. A changed data distribution does not always mean performance has degraded, so monitoring should evaluate both.

SaMD and AI · IVD and diagnostics · Electrical and connected devices

Why it matters for founders: Define monitoring thresholds and responses rather than assuming validation performance will persist indefinitely.

Related: GMLP, PCCP, Postmarket Surveillance

AI/ML PCCP Suite

$399 USD · One-time · Applicable taxes may apply

Buy the Kit
MS-DRGMedicare Severity Diagnosis Related Group
Market access

MS-DRGs group Medicare inpatient stays by diagnosis, procedure and severity; each group sets the hospital's fixed payment for the stay.

Cross-device relevance

Why it matters for founders: A new device's cost is usually absorbed in the DRG payment, so the DRG drives hospital economics and NTAP eligibility.

Related: NTAP, NTAP cost threshold

Hospital VAC Dossier Pack

$299 USD · One-time · Applicable taxes may apply

Buy the Kit
NIS 2Directive (EU) 2022/2555
Risk and postmarket

The EU directive setting cybersecurity risk-management and incident-reporting duties for essential and important entities, including healthcare providers and some medical device manufacturers.

Cross-device relevance

Why it matters for founders: EU hospitals must manage supply-chain cybersecurity risk, so they ask AI vendors for security and incident-response commitments.

Related: NIST CSF, EU GDPR

NIST AI RMFNIST AI Risk Management Framework (AI RMF 1.0)
AI and software

A voluntary NIST framework, released in January 2023, that helps organizations manage AI risks through four functions: Govern, Map, Measure and Manage.

Cross-device relevance

Why it matters for founders: It is a common, vendor-neutral structure for hospital AI governance policies and vendor risk reviews.

Related: OECD AI Principles, EU AI Act, Procurement Readiness Score

NIST CSFNIST Cybersecurity Framework 2.0
Risk and postmarket

NIST's voluntary cybersecurity framework; version 2.0 (2024) organizes outcomes into six functions: Govern, Identify, Protect, Detect, Respond and Recover.

Cross-device relevance

Why it matters for founders: Hospitals often map vendor and device security controls to CSF outcomes during procurement.

Related: SOC 2, NIS 2

Notified Body
Market access

A Notified Body is an organization designated by an EU member state to assess whether medium- and high-risk devices conform to the EU MDR before CE marking.

Cross-device relevance

Why it matters for founders: Notified Body capacity and review times often set the timeline for EU launch.

Related: EU MDR, CE Marking, Clinical Evaluation Report (CER)

NTAPNew Technology Add-on Payment
Market access

NTAP is a temporary Medicare add-on paid to hospitals for qualifying inpatient cases involving approved new technologies. The traditional eligibility criteria are newness, cost and substantial clinical improvement, with specified transitional pathway exceptions.

Cross-device relevance

Why it matters for founders: It may offset some additional case costs, but does not guarantee coverage, hospital profit or two to three paid years after approval. NTAP Analyzer supports cost-criterion planning, not a complete eligibility or payment determination.

Related: NTAP cost threshold, MS-DRG, NTAP newness, Substantial clinical improvement (SCI)

NTAP Master Workbook

$499 USD · One-time · Applicable taxes may apply

Buy the Kit
NTAP alternative pathway and grandfathering
Market access

Alternative pathways provide specified eligibility treatment for qualifying categories. The FY 2027 final rule repeals them for FY 2028 applications except specified transitional provisions through FY 2029.

Cross-device relevance

Why it matters for founders: Breakthrough designation does not guarantee NTAP. Confirm category, designation and authorization dates, indication, cost evidence and annual deadlines against current CMS rules.

Related: NTAP, Breakthrough Device Designation, Substantial clinical improvement (SCI)

NTAP cost threshold
Market access

A CMS-published comparison value used to assess estimated standardized case charges for the NTAP cost criterion, using the relevant MS-DRGs and applicable case weighting. It is not the device price or the hospital's DRG payment.

Cross-device relevance

Why it matters for founders: Use the threshold file for the target application cycle, including corrections, rather than relying on the label Table 10 alone. The Analyzer pre-fills reference thresholds; a favorable screen is not CMS approval.

Related: NTAP, MS-DRG, NTAP standardized case charges, Cost-to-charge ratio (CCR)

NTAP Master Workbook

$499 USD · One-time · Applicable taxes may apply

Buy the Kit
NTAP newness
Market access

Newness assesses whether a technology is still new for Medicare inpatient payment, considering coding, available data for DRG recalibration and substantial similarity to existing technology.

Cross-device relevance

Why it matters for founders: FDA authorization alone does not establish newness, and the two-to-three-year framework does not guarantee that many years of payment after NTAP approval.

Related: NTAP, Substantial clinical improvement (SCI)

NTAP payment limit
Market access

For qualifying discharges, the general NTAP payment is limited to the lesser of 65% of technology costs or 65% of case costs above the relevant DRG payment, subject to approved limits and claim requirements. Specified categories have 75% rules.

Cross-device relevance

Why it matters for founders: The percentage is not applied directly to gross charges, and the maximum approved add-on is not guaranteed payment on every case. The Analyzer is not a claim-payment or margin calculator.

Related: NTAP, NTAP cost threshold, Cost-to-charge ratio (CCR)

NTAP standardized case charges
Market access

For the NTAP cost criterion, CMS assesses estimated charges for cases involving a technology with applicable standardization and relevant DRG weighting, not the device selling price alone.

Cross-device relevance

Why it matters for founders: Include the relevant stay and replacement effects, document the baseline and use the correctly labeled application threshold file and corrections.

Related: NTAP cost threshold, Cost-to-charge ratio (CCR), MS-DRG

OECD AI Principles
AI and software

Intergovernmental principles adopted in 2019 (updated 2024) promoting AI that is innovative, trustworthy and respects human rights and democratic values, including transparency, robustness and accountability.

Cross-device relevance

Why it matters for founders: They underpin many national AI policies and give governance committees shared language for responsible AI.

Related: NIST AI RMF, EU AI Act

Patient Registry
Development and clinical

A patient registry is an organized system collecting data about people with a condition, exposure or treatment to evaluate specified outcomes. Registries can be a source of real-world data when information is routinely collected.

Cross-device relevance

Why it matters for founders: Define outcomes, follow-up and data quality early if registry data will support device evidence.

Related: Real-World Data (RWD), Real-World Evidence (RWE), Clinical Evidence

Payer Coverage
Market access

Payer coverage is a health plan's determination of whether a service or product is eligible for benefits under specified conditions. Medicare uses national and local coverage decisions for many services.

Cross-device relevance

Why it matters for founders: A billing code alone does not demonstrate that a payer will cover a device-related service.

Related: Reimbursement, CPT and HCPCS codes, Clinical Evidence

Reimbursement & Coding Roadmap

$299 USD · One-time · Applicable taxes may apply

Buy the Kit
PCCPPredetermined Change Control Plan
AI and software

A Predetermined Change Control Plan (PCCP) is the part of a marketing submission that describes planned device modifications, how they will be developed and validated, and their impact assessment, so authorized changes can be made without a new submission.

SaMD and AI · IVD and diagnostics · Electrical and connected devices

Why it matters for founders: For AI/ML devices, an authorized PCCP lets you update models faster — but every change must still be executed under your quality system.

Related: GMLP, SaMD, QMSR

AI/ML PCCP Suite

$399 USD · One-time · Applicable taxes may apply

Buy the Kit
Periodic Safety Update Report (PSUR)
Risk and postmarket

Under EU MDR Article 86, the PSUR summarizes postmarket data analysis, benefit-risk conclusions and preventive or corrective actions for Class IIa, IIb and III devices. Update frequency depends on class; IVDR has separate provisions for Class C and D IVDs.

SaMD and AI · Implantable devices · Electrical and connected devices · General medical devices

Why it matters for founders: Allocate owners and a reporting schedule for postmarket evidence before launch.

Related: Post-Market Clinical Follow-up (PMCF), EU MDR, Postmarket Surveillance

PMAPremarket Approval
Premarket

Premarket Approval (PMA) is FDA's most stringent review pathway, requiring valid scientific evidence that a Class III device is safe and effective.

Cross-device relevance

Why it matters for founders: PMAs usually need clinical data and a pre-approval inspection, so timelines and costs are much higher than a 510(k).

Related: IDE, 510(k), Q-Sub (Pre-Sub)

FDA Q-Sub Master Pack

$499 USD · One-time · Applicable taxes may apply

Buy the Kit
Post-Market Clinical Follow-up (PMCF)
Risk and postmarket

Under the EU MDR, PMCF is a continuous process that updates clinical evaluation by collecting and evaluating clinical data from use of a CE-marked device within its intended purpose. The plan must address the need for PMCF or justify why it is not applicable.

SaMD and AI · Implantable devices · Electrical and connected devices · General medical devices

Why it matters for founders: Plan ongoing clinical evidence collection and incorporate findings into clinical evaluation and risk management.

Related: Clinical Evaluation Report (CER), EU MDR, Postmarket Surveillance

Postmarket SurveillancePost-Market Surveillance (PMS)
Risk and postmarket

Postmarket surveillance is the active, systematic collection, analysis and interpretation of information about a marketed device's safety and performance. General lifecycle monitoring is distinct from an FDA section 522 surveillance order, which can require studies for certain Class II or III devices.

Cross-device relevance

Why it matters for founders: It feeds complaint handling, risk files, CAPA and — for AI devices — model performance monitoring.

Related: MDR (Medical Device Reporting), CAPA, ISO 14971

Predicate Device
Premarket

A predicate device is a legally marketed device that a 510(k) compares a new device against to show substantial equivalence.

Cross-device relevance

Why it matters for founders: Choosing the right predicate determines which differences you must explain and what performance data FDA will expect.

Related: 510(k), Substantial Equivalence

FDA Q-Sub Master Pack

$499 USD · One-time · Applicable taxes may apply

Buy the Kit
Process Validation
Manufacturing and supply chain

Process validation establishes documented evidence that a process consistently produces results meeting specified requirements. ISO 13485 requires validation where the resulting output cannot be, or is not, verified by subsequent monitoring or measurement.

Cross-device relevance

Why it matters for founders: Sterilization, bonding and other special processes may need validation before commercial release.

Related: Medical Device Manufacturing, IQ / OQ / PQ, Sterilization Validation

Procurement Readiness ScorePRS
AI and software

Cahir's Procurement Readiness Score (PRS) is a 100-point score that weights an AI-enabled medical device's clinical (40%), technical (35%) and operational (25%) evidence and places it in a Ready, Conditional or Not ready band.

Cross-device relevance

Why it matters for founders: It gives hospital committees one comparable view of vendors before contracting, instead of relying on demos.

Related: NIST AI RMF, FDA AI-enabled device guidance

Product Code
Premarket

An FDA product code is a three-letter identifier tied to a device type's classification regulation, class and review panel.

Cross-device relevance

Why it matters for founders: Searching FDA databases by product code is the fastest way to find predicates, recognized standards and competitor clearances.

Related: Device Classification (Class I, II, III), Predicate Device

Q-Sub (Pre-Sub)Q-Submission / Pre-Submission
Premarket

A Q-Submission (Q-Sub) is a formal request for FDA feedback; the Pre-Submission type lets you ask specific questions about your planned testing or submission before you file.

Cross-device relevance

Why it matters for founders: Well-framed questions get actionable written feedback that can prevent costly testing or pathway mistakes.

Related: 510(k), De Novo, IDE

FDA Q-Sub Master Pack

$499 USD · One-time · Applicable taxes may apply

Buy the Kit
QMSQuality Management System
Quality system

A quality management system (QMS) is the documented set of processes, responsibilities and records a company uses to consistently make safe, effective devices.

Cross-device relevance

Why it matters for founders: A right-sized QMS started early is cheaper than retrofitting one before submission or inspection.

Related: ISO 13485, QMSR, CAPA

21 CFR to ISO 13485 Mapping Kit

$199 USD · One-time · Applicable taxes may apply

Buy the Kit
QMSRQuality Management System Regulation
Quality system

The QMSR is FDA's amended 21 CFR Part 820, effective February 2, 2026, which incorporates ISO 13485:2016 by reference as the US device quality system requirement.

Cross-device relevance

Why it matters for founders: It replaced the old Quality System Regulation; FDA now inspects to ISO 13485 plus US-specific requirements.

Related: ISO 13485, QMS, DHF, Form 483

21 CFR to ISO 13485 Mapping Kit

$199 USD · One-time · Applicable taxes may apply

Buy the Kit
Real-World Data (RWD)
Development and clinical

Real-world data are data about patient health status or delivery of health care routinely collected from sources such as health records, claims, registries and devices. Analysis of fit-for-purpose RWD can generate real-world evidence.

Cross-device relevance

Why it matters for founders: Data availability alone does not establish relevance, reliability or suitability for a regulatory question.

Related: Real-World Evidence (RWE), Patient Registry, Postmarket Surveillance

Real-World Evidence (RWE)
Risk and postmarket

Real-world evidence is clinical evidence about a device's use, benefits or risks derived from analyzing real-world data such as registries, health records and claims.

Cross-device relevance

Why it matters for founders: FDA may accept RWE to support some premarket and postmarket decisions when the data are relevant and reliable.

Related: Postmarket Surveillance, IDE, Real-World Data (RWD)

Recall
Risk and postmarket

A recall is a firm's removal or correction of a marketed device that FDA considers violative; FDA classifies recalls as Class I, II or III by health risk.

Cross-device relevance

Why it matters for founders: Corrections and removals may also require a report to FDA under 21 CFR Part 806.

Related: CAPA, UDI, Postmarket Surveillance

Reimbursement
Market access

Reimbursement is payment by a payer for a health service, procedure or product under its rules. Coding identifies what was provided, coverage decides eligibility for benefits, and payment determines the amount and method.

Cross-device relevance

Why it matters for founders: FDA authorization does not guarantee coverage or payment; plan the economic evidence separately.

Related: CPT and HCPCS codes, Payer Coverage, Value Analysis Committee (VAC)

Reimbursement & Coding Roadmap

$299 USD · One-time · Applicable taxes may apply

Buy the Kit
Requirements Traceability Matrix (RTM)
Development and clinical

A requirements traceability matrix is a practical way to link user needs, design inputs, outputs, risk controls and verification or validation evidence. The matrix is a documentation tool, not a universally mandated file format.

Cross-device relevance

Why it matters for founders: It reveals missing evidence and makes change impact reviews easier.

Related: Design Inputs, Verification and Validation (V&V), ISO 14971

SaMDSoftware as a Medical Device
AI and software

Software as a Medical Device (SaMD) is software intended for medical purposes that performs those purposes without being part of a hardware device.

SaMD and AI · IVD and diagnostics · Electrical and connected devices

Why it matters for founders: SaMD still needs design controls, cybersecurity documentation and, often, a premarket submission.

Related: PCCP, GMLP, SBOM

AI/ML PCCP Suite

$399 USD · One-time · Applicable taxes may apply

Buy the Kit
SBOMSoftware Bill of Materials
AI and software

A software bill of materials (SBOM) lists the commercial, open-source and off-the-shelf software components in a device.

SaMD and AI · IVD and diagnostics · Electrical and connected devices

Why it matters for founders: FDA requires an SBOM in premarket submissions for cyber devices under section 524B of the FD&C Act.

Related: SaMD, eSTAR

Section 506J Shortage Notification
Manufacturing and supply chain

Section 506J requires manufacturers of certain devices to notify FDA of specified discontinuances or manufacturing interruptions likely to meaningfully disrupt US supply during or in advance of a public health emergency. FDA also accepts voluntary notifications outside that context.

Cross-device relevance

Why it matters for founders: Check the current 506J device list and notification criteria; this is not a universal duty for every routine delay.

Related: Medical Device Supply Chain, Medical Device Manufacturing

Shelf Life
Manufacturing and supply chain

Shelf life is the period during which a device is expected to remain within specified safety and performance requirements under defined storage conditions. Evidence may address material stability, reagent performance or sterile-barrier integrity.

IVD and diagnostics · Implantable devices · General medical devices · Electrical and connected devices

Why it matters for founders: Expiry claims affect testing, inventory planning and packaging decisions.

Related: Sterilization Validation, Verification and Validation (V&V), Labeling

SOC 2
Risk and postmarket

An AICPA attestation report in which an independent auditor evaluates a service organization's controls for security, availability, processing integrity, confidentiality and privacy.

Cross-device relevance

Why it matters for founders: A SOC 2 Type II report is common evidence in vendor security reviews of cloud-hosted AI tools.

Related: NIST CSF, FedRAMP, HIPAA

Sterilization Validation
Manufacturing and supply chain

Sterilization validation demonstrates that a defined sterilization process can consistently achieve the specified sterility assurance level for the product and its packaging. Applicable standards depend on the sterilization method.

Implantable devices · General medical devices · IVD and diagnostics · Electrical and connected devices

Why it matters for founders: Changes to materials, packaging or the process may require evaluation and revalidation.

Related: Process Validation, ISO 10993 (Biocompatibility), Shelf Life

Substantial clinical improvement (SCI)NTAP substantial clinical improvement
Market access

SCI is CMS's assessment of a meaningful advance in diagnosis or treatment compared with previously available options for Medicare beneficiaries, using the totality of relevant evidence.

Cross-device relevance

Why it matters for founders: A favorable cost screen or FDA authorization does not establish SCI. The Analyzer evaluates cost-criterion planning, not clinical eligibility.

Related: NTAP, Clinical Evidence, NTAP alternative pathway and grandfathering

Substantial Equivalence
Premarket

Substantial equivalence means a new device has the same intended use as its predicate and either the same technological characteristics or differences that do not raise different safety and effectiveness questions.

Cross-device relevance

Why it matters for founders: It is the legal standard FDA applies in every 510(k) decision.

Related: 510(k), Predicate Device

FDA Q-Sub Master Pack

$499 USD · One-time · Applicable taxes may apply

Buy the Kit
Supplier Controls
Quality system

Supplier (purchasing) controls are the QMS processes for evaluating, selecting, monitoring and documenting suppliers based on their effect on device quality.

Cross-device relevance

Why it matters for founders: Contract manufacturers and critical component suppliers are your responsibility; investigators frequently cite weak supplier oversight.

Related: QMS, CAPA, ISO 13485

21 CFR to ISO 13485 Mapping Kit

$199 USD · One-time · Applicable taxes may apply

Buy the Kit
Supply Chain Resilience
Manufacturing and supply chain

Supply chain resilience is the ability to anticipate, withstand and recover from supply disruptions while maintaining access to safe, effective devices. It can include risk assessment, qualified alternatives and continuity planning.

Cross-device relevance

Why it matters for founders: A single critical supplier can become a launch or patient-access bottleneck.

Related: Medical Device Supply Chain, Supplier Controls, Section 506J Shortage Notification

Total Product Life Cycle (TPLC)
Development and clinical

The total product life cycle covers a device from concept and development through manufacturing, marketing, use, monitoring and eventual retirement. Evidence from later stages informs earlier design and risk decisions.

Cross-device relevance

Why it matters for founders: Plan for production and postmarket evidence before launch, rather than treating clearance as the finish line.

Related: Design Controls, Medical Device Manufacturing, Postmarket Surveillance

UDIUnique Device Identification
Risk and postmarket

Unique Device Identification (UDI) is FDA's system requiring device labels to carry a unique identifier, with device data submitted to the GUDID database.

Cross-device relevance

Why it matters for founders: UDI supports recalls, adverse event reporting and hospital supply chains, and must be planned into labeling.

Related: DHR, Postmarket Surveillance

UKCAUK Conformity Assessed
Market access

UKCA is the conformity marking for placing medical devices on the Great Britain market, overseen by the MHRA.

Cross-device relevance

Why it matters for founders: Transitional arrangements currently allow CE-marked devices in Great Britain, but timelines should be checked against current MHRA guidance.

Related: EU MDR

Value Analysis Committee (VAC)
Market access

A hospital value analysis committee (VAC) is the group of clinical, supply chain and finance staff that decides whether to purchase a new product.

Cross-device relevance

Why it matters for founders: Clinical evidence alone rarely wins; VACs expect budget impact, workflow and outcome data.

Related: CPT and HCPCS codes

Hospital VAC Dossier Pack

$299 USD · One-time · Applicable taxes may apply

Buy the Kit
Verification and Validation (V&V)
Quality system

Design verification confirms that design outputs meet design inputs; design validation confirms that the finished device meets user needs and intended uses.

Cross-device relevance

Why it matters for founders: V&V results are the core test evidence in a premarket submission and in your design records.

Related: Design Controls, DHF, Human Factors / Usability Engineering

Warning Letter
Quality system

An FDA Warning Letter is a public notice that FDA considers a company to be in significant violation of regulatory requirements.

Cross-device relevance

Why it matters for founders: Warning Letters are published and can block certificates to foreign governments and premarket approvals until resolved.

Related: Form 483, CAPA

QMSR Form 483 Response Kit

$299 USD · One-time · Applicable taxes may apply

Buy the Kit

Definitions are plain-language summaries for orientation, not legal or regulatory advice. Always confirm against the linked official source.

Ready to put these terms to work?

Practical workbooks turn PCCP, QMSR, Q-Sub and inspection requirements into owned, evidence-backed tasks.